These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 5059651)

  • 1. Sickle cell disease.
    Ranney HM
    Blood; 1972 Mar; 39(3):433-9. PubMed ID: 5059651
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyanate as an inhibitor of red-cell sickling.
    Cerami A
    N Engl J Med; 1972 Oct; 287(16):807-12. PubMed ID: 4560520
    [No Abstract]   [Full Text] [Related]  

  • 3. New drugs in the treatment of sickle cell anemia.
    Freedman ML
    Am J Med Sci; 1973 May; 265(5):371-3. PubMed ID: 4576757
    [No Abstract]   [Full Text] [Related]  

  • 4. Urea, cyanate and sickling.
    Harris A
    N Engl J Med; 1971 Sep; 285(12):690-1. PubMed ID: 5563487
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyanate and sickling.
    Charache S; Diederich D
    N Engl J Med; 1971 Nov; 285(20):1147. PubMed ID: 5095746
    [No Abstract]   [Full Text] [Related]  

  • 6. The treatment of sickle-cell disease.
    Lancet; 1972 Mar; 1(7752):671-2. PubMed ID: 4125168
    [No Abstract]   [Full Text] [Related]  

  • 7. Carbamylation of the chains of hemoglobin S by cyanate in vitro and in vivo.
    Njikam N; Jones WM; Nigen AM; Gillette PN; Williams RC; Manning JM
    J Biol Chem; 1973 Dec; 248(23):8052-6. PubMed ID: 4752945
    [No Abstract]   [Full Text] [Related]  

  • 8. Relationship between the oxygen affinity and in vitro sickling propensity of carbamylated sickle erythrocytes.
    Diederich D
    Biochem Biophys Res Commun; 1972 Feb; 46(3):1255-61. PubMed ID: 5012168
    [No Abstract]   [Full Text] [Related]  

  • 9. Some comparative aspects of carbamylation of human blood and of hemoglobin with cyanate and carbamyl phosphate.
    Carreras-Barnes J; Diederich DA; Grisolia S
    Eur J Biochem; 1972 May; 27(1):103-8. PubMed ID: 5049047
    [No Abstract]   [Full Text] [Related]  

  • 10. Urea, urease, cyanate, and the sickling of hemoglobin S.
    Nalbandian RM; Nichols BM; Stehouwer EJ; Camp FR
    Clin Chem; 1972 Sep; 18(9):961-4. PubMed ID: 5052097
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of urea and cyanate on sickling in vitro.
    Segel GB; Feig SA; Mentzer WC; McCaffrey RP; Wells R; Bunn HF; Shohet SB; Nathan DG
    N Engl J Med; 1972 Jul; 287(2):59-64. PubMed ID: 5031386
    [No Abstract]   [Full Text] [Related]  

  • 12. An extracorporeal system that modifies hemoglobin in patients with sickle cell anemia.
    Babb AL; Scribner BH; Uvelli DA; Fry DL; Agodoa LC
    Artif Organs; 1979 Feb; 3(1):62-72. PubMed ID: 435126
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapy of sickle cell disease: an approach with sodium cyanate.
    Peterson CM; Cerami A
    Semin Hematol; 1974 Oct; 11(4):569-76. PubMed ID: 4213637
    [No Abstract]   [Full Text] [Related]  

  • 14. The clinical use of cyanate in sickling.
    Ranney HM
    N Engl J Med; 1972 Jul; 287(2):98-100. PubMed ID: 4624186
    [No Abstract]   [Full Text] [Related]  

  • 15. Sickle cell disease: clinical advances by the Murayama molecular hypothesis.
    Nalbandian RM; Henry RL; Barnhart MI; Camp FR
    Mil Med; 1972 Jun; 137(6):215-20. PubMed ID: 4625667
    [No Abstract]   [Full Text] [Related]  

  • 16. Sickle cell anemia and dietary precursors of cyanate.
    Houston RG
    Am J Clin Nutr; 1973 Nov; 26(11):1261-4. PubMed ID: 4594066
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of carbamylation of Hb-S on the sickling process.
    May A; Huehns ER; Beaven GH
    Clin Sci; 1972 Apr; 42(4):20P-21P. PubMed ID: 5020278
    [No Abstract]   [Full Text] [Related]  

  • 18. Extracorporeal treatment of erythrocytes in sickle cell anemia: hemoglobin carbamylation.
    Diederich D; Curran M; Odenbaugh A; Diederich A; Core E
    Tex Rep Biol Med; 1980-1981; 40():313-22. PubMed ID: 7323976
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased survival of sickle-cell erythrocytes after treatment in vitro with sodium cyanate.
    Gillette PN; Manning JM; Cerami A
    Proc Natl Acad Sci U S A; 1971 Nov; 68(11):2791-3. PubMed ID: 5288258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of the blood concentrations of cyanate after intravenous administration to patients with sickle-cell disease.
    Nigen AM; Peterson CM; Gillette PN; Manning JM
    J Lab Clin Med; 1974 Jan; 83(1):139-46. PubMed ID: 4808651
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.